"Background And Objective: OSMF is an avancing premalignant condition for which a reliable treatment modality has not yet evolved. The aim of the present study was to evaluate the efficacy of newer anti-oxidant - Lycopene in the treatment of OSMF."
Co-Author Dr. Durgesh Bailoor (standing left)
No comments:
Post a Comment